Exploring the Benefits of SGLT2 Inhibitors in Chronic Kidney Disease

home / medcast-videos / exploring-the-benefits-of-sglt2-inhibitors-in-chronic-kidney-disease

Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, and Natalie Bellini, DNP, FNP:-BC, interview Dr Robert Busch, to explore the advantages of SGLT2 inhibitors in chronic kidney disease, cardiovascular health, and their potential to improve overall patient outcomes.

© 2023 MJH Life Sciences

All rights reserved.